These results may indicate that infection and IL-21 treatment is affecting IL-21R expression on existing plasmablasts and plasma cells, or that KSHV and IL-21 synergistically drive differentiation of IL-21R+ cells to plasmablast and plasma cell phenotypes. The gene discussed is IL21; the disease is infection.